{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:21:33Z","timestamp":1792650093004,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T00:00:00Z","timestamp":1675296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T00:00:00Z","timestamp":1675296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The impairment in the autophagy-lysosomal pathway (ALP) and the activation of NLR family pyrin domain containing 3 (NLRP3) inflammasome represent two molecular events leading to neurodegeneration and neuroinflammation in Alzheimer\u2019s disease (AD), a devastating neurodegenerative disorder without a cure. Previously we demonstrated the cognitive-enhancing effect of a combined electroacupuncture (EA) therapy termed TNEA in a transgenic mouse model of AD, involving activation of transcription factor EB (TFEB), a master regulator of ALP. However, whether and how TNEA inhibits NLRP3 inflammasome via TFEB-mediated ALP in AD remains to be investigated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>5xFAD mice overexpressing amyloid-\u03b2 (A\u03b2) were treated with TNEA or EA on its composing acupoints (GB13 and GV24). The changes in the signaling pathways regulating NLRP3 inflammasome, the association of NLRP3 inflammasome with ALP, and the roles of TFEB\/TFE3 in mice brains were determined by immunoblots, immunohistochemistry and AAV-mediated knockdown assays.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>TNEA inhibits the activation of NLRP3 inflammasome and the release of active interleukin 1\u03b2 (IL1B) in the hippocampi of 5xFAD mice. Mechanistically, TNEA promoted the autophagic degradation of inflammasome components via activating both TFEB and TFE3 by modulating kinases including AMPK and AKT. The composing acupoints in TNEA showed synergistic effects on regulating these molecular events and memory improvement.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our findings suggest that TNEA attenuates AD-associated memory impairment via promoting TFEB\/TFE3-mediated autophagic clearance of A\u03b2 and NLRP3 inflammasome, and partially reveal the molecular basis of combined acupoints therapy originated from ancient wisdom.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12974-023-02698-w","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T16:30:36Z","timestamp":1675355436000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["TNEA therapy promotes the autophagic degradation of NLRP3 inflammasome in a transgenic mouse model of Alzheimer\u2019s disease via TFEB\/TFE3 activation"],"prefix":"10.1186","volume":"20","author":[{"given":"Wenjia","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangfeng","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runjin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingwei","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengfu","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nenggui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunzhi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Xian","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,2]]},"reference":[{"key":"2698_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2019.100966","volume":"56","author":"CF Pereira","year":"2019","unstructured":"Pereira CF, Santos AE, Moreira PI, Pereira AC, Sousa FJ, Cardoso SM, et al. Is Alzheimer\u2019s disease an inflammasomopathy? Ageing Res Rev. 2019;56: 100966.","journal-title":"Ageing Res Rev"},{"issue":"3","key":"2698_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/ni.3102","volume":"16","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Golenbock DT, Latz E. Innate immunity in Alzheimer\u2019s disease. Nat Immunol. 2015;16(3):229\u201336.","journal-title":"Nat Immunol"},{"issue":"8","key":"2698_CR3","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/ni.1636","volume":"9","author":"A Halle","year":"2008","unstructured":"Halle A, Hornung V, Petzold GC, Stewart CR, Monks BG, Reinheckel T, et al. The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol. 2008;9(8):857\u201365.","journal-title":"Nat Immunol"},{"issue":"7434","key":"2698_CR4","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nature11729","volume":"493","author":"MT Heneka","year":"2013","unstructured":"Heneka MT, Kummer MP, Stutz A, Delekate A, Schwartz S, Vieira-Saecker A, et al. NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice. Nature. 2013;493(7434):674\u20138.","journal-title":"Nature"},{"issue":"7685","key":"2698_CR5","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/nature25158","volume":"552","author":"C Venegas","year":"2017","unstructured":"Venegas C, Kumar S, Franklin BS, Dierkes T, Brinkschulte R, Tejera D, et al. Microglia-derived ASC specks cross-seed amyloid-beta in Alzheimer\u2019s disease. Nature. 2017;552(7685):355\u201361.","journal-title":"Nature"},{"issue":"7784","key":"2698_CR6","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","volume":"575","author":"C Ising","year":"2019","unstructured":"Ising C, Venegas C, Zhang S, Scheiblich H, Schmidt SV, Vieira-Saecker A, et al. NLRP3 inflammasome activation drives tau pathology. Nature. 2019;575(7784):669\u201373.","journal-title":"Nature"},{"issue":"1","key":"2698_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41392-020-0145-7","volume":"5","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Dong Z, Song W. NLRP3 inflammasome as a novel therapeutic target for Alzheimer\u2019s disease. Signal Transduct Target Ther. 2020;5(1):37.","journal-title":"Signal Transduct Target Ther"},{"key":"2698_CR8","doi-asserted-by":"publisher","first-page":"12504","DOI":"10.1038\/ncomms12504","volume":"7","author":"MJ Daniels","year":"2016","unstructured":"Daniels MJ, Rivers-Auty J, Schilling T, Spencer NG, Watremez W, Fasolino V, et al. Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer\u2019s disease in rodent models. Nat Commun. 2016;7:12504.","journal-title":"Nat Commun"},{"key":"2698_CR9","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.bbi.2016.12.014","volume":"61","author":"C Dempsey","year":"2017","unstructured":"Dempsey C, Rubio Araiz A, Bryson KJ, Finucane O, Larkin C, Mills EL, et al. Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-beta and cognitive function in APP\/PS1 mice. Brain Behav Immun. 2017;61:306\u201316.","journal-title":"Brain Behav Immun"},{"issue":"47","key":"2698_CR10","doi-asserted-by":"publisher","first-page":"23426","DOI":"10.1073\/pnas.1916318116","volume":"116","author":"MH Park","year":"2019","unstructured":"Park MH, Lee M, Nam G, Kim M, Kang J, Choi BJ, et al. N, N\u2032-Diacetyl-p-phenylenediamine restores microglial phagocytosis and improves cognitive defects in Alzheimer\u2019s disease transgenic mice. Proc Natl Acad Sci USA. 2019;116(47):23426\u201336.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"50","key":"2698_CR11","doi-asserted-by":"publisher","first-page":"32145","DOI":"10.1073\/pnas.2009680117","volume":"117","author":"N Lonnemann","year":"2020","unstructured":"Lonnemann N, Hosseini S, Marchetti C, Skouras DB, Stefanoni D, D\u2019Alessandro A, et al. The NLRP3 inflammasome inhibitor OLT1177 rescues cognitive impairment in a mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci USA. 2020;117(50):32145\u201354.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"2698_CR12","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41593-022-01084-8","volume":"25","author":"JH Lee","year":"2022","unstructured":"Lee JH, Yang DS, Goulbourne CN, Im E, Stavrides P, Pensalfini A, et al. Faulty autolysosome acidification in Alzheimer\u2019s disease mouse models induces autophagic build-up of Abeta in neurons, yielding senile plaques. Nat Neurosci. 2022;25(6):688\u2013701.","journal-title":"Nat Neurosci"},{"issue":"3","key":"2698_CR13","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.apsb.2022.01.008","volume":"12","author":"W Zhang","year":"2022","unstructured":"Zhang W, Xu C, Sun J, Shen HM, Wang J, Yang C. Impairment of the autophagy-lysosomal pathway in Alzheimer\u2019s diseases: Pathogenic mechanisms and therapeutic potential. Acta Pharm Sin B. 2022;12(3):1019\u201340.","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"2698_CR14","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.drudis.2020.10.013","volume":"26","author":"JX Song","year":"2021","unstructured":"Song JX, Liu J, Jiang Y, Wang ZY, Li M. Transcription factor EB: an emerging drug target for neurodegenerative disorders. Drug Discov Today. 2021;26(1):164\u201372.","journal-title":"Drug Discov Today"},{"issue":"4","key":"2698_CR15","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.tins.2016.02.002","volume":"39","author":"H Martini-Stoica","year":"2016","unstructured":"Martini-Stoica H, Xu Y, Ballabio A, Zheng H. The autophagy-lysosomal pathway in neurodegeneration: a TFEB perspective. Trends Neurosci. 2016;39(4):221\u201334.","journal-title":"Trends Neurosci"},{"issue":"9","key":"2698_CR16","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nrd.2018.109","volume":"17","author":"B Boland","year":"2018","unstructured":"Boland B, Yu WH, Corti O, Mollereau B, Henriques A, Bezard E, et al. Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing. Nat Rev Drug Discov. 2018;17(9):660\u201388.","journal-title":"Nat Rev Drug Discov"},{"issue":"309","key":"2698_CR17","doi-asserted-by":"publisher","first-page":"ra9","DOI":"10.1126\/scisignal.2004754","volume":"7","author":"JA Martina","year":"2014","unstructured":"Martina JA, Diab HI, Lishu L, Jeong AL, Patange S, Raben N, et al. The nutrient-responsive transcription factor TFE3 promotes autophagy, lysosomal biogenesis, and clearance of cellular debris. Sci Signal. 2014;7(309):ra9.","journal-title":"Sci Signal."},{"issue":"8","key":"2698_CR18","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1080\/15548627.2016.1179405","volume":"12","author":"N Pastore","year":"2016","unstructured":"Pastore N, Brady OA, Diab HI, Martina JA, Sun L, Huynh T, et al. TFEB and TFE3 cooperate in the regulation of the innate immune response in activated macrophages. Autophagy. 2016;12(8):1240\u201358.","journal-title":"Autophagy"},{"issue":"6036","key":"2698_CR19","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1126\/science.1204592","volume":"332","author":"C Settembre","year":"2011","unstructured":"Settembre C, Di Malta C, Polito VA, Garcia Arencibia M, Vetrini F, Erdin S, et al. TFEB links autophagy to lysosomal biogenesis. Science. 2011;332(6036):1429\u201333.","journal-title":"Science"},{"issue":"12","key":"2698_CR20","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1080\/15548627.2016.1239003","volume":"12","author":"M Bordi","year":"2016","unstructured":"Bordi M, Berg MJ, Mohan PS, Peterhoff CM, Alldred MJ, Che S, et al. Autophagy flux in CA1 neurons of Alzheimer hippocampus: Increased induction overburdens failing lysosomes to propel neuritic dystrophy. Autophagy. 2016;12(12):2467\u201383.","journal-title":"Autophagy"},{"key":"2698_CR21","doi-asserted-by":"publisher","first-page":"4732837","DOI":"10.1155\/2016\/4732837","volume":"2016","author":"H Wang","year":"2016","unstructured":"Wang H, Wang R, Xu S, Lakshmana MK. Transcription factor EB is selectively reduced in the nuclear fractions of alzheimer\u2019s and amyotrophic lateral sclerosis brains. Neurosci J. 2016;2016:4732837.","journal-title":"Neurosci J"},{"issue":"2","key":"2698_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13069","volume":"19","author":"JX Song","year":"2020","unstructured":"Song JX, Malampati S, Zeng Y, Durairajan SSK, Yang CB, Tong BC, et al. A small molecule transcription factor EB activator ameliorates beta-amyloid precursor protein and Tau pathology in Alzheimer\u2019s disease models. Aging Cell. 2020;19(2): e13069.","journal-title":"Aging Cell"},{"issue":"35","key":"2698_CR23","doi-asserted-by":"publisher","first-page":"12137","DOI":"10.1523\/JNEUROSCI.0705-15.2015","volume":"35","author":"Q Xiao","year":"2015","unstructured":"Xiao Q, Yan P, Ma X, Liu H, Perez R, Zhu A, et al. Neuronal-targeted TFEB accelerates lysosomal degradation of APP, reducing abeta generation and amyloid plaque pathogenesis. J Neurosci. 2015;35(35):12137\u201351.","journal-title":"J Neurosci"},{"issue":"9","key":"2698_CR24","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.15252\/emmm.201303671","volume":"6","author":"VA Polito","year":"2014","unstructured":"Polito VA, Li H, Martini-Stoica H, Wang B, Yang L, Xu Y, et al. Selective clearance of aberrant tau proteins and rescue of neurotoxicity by transcription factor EB. EMBO Mol Med. 2014;6(9):1142\u201360.","journal-title":"EMBO Mol Med"},{"key":"2698_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.591803","volume":"11","author":"M Biasizzo","year":"2020","unstructured":"Biasizzo M, Kopitar-Jerala N. Interplay between NLRP3 inflammasome and autophagy. Front Immunol. 2020;11: 591803.","journal-title":"Front Immunol"},{"key":"2698_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2020.101202","volume":"65","author":"AG Wu","year":"2021","unstructured":"Wu AG, Zhou XG, Qiao G, Yu L, Tang Y, Yan L, et al. Targeting microglial autophagic degradation in NLRP3 inflammasome-mediated neurodegenerative diseases. Ageing Res Rev. 2021;65: 101202.","journal-title":"Ageing Res Rev"},{"issue":"1","key":"2698_CR27","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s41232-022-00209-7","volume":"42","author":"XG Zhou","year":"2022","unstructured":"Zhou XG, Qiu WQ, Yu L, Pan R, Teng JF, Sang ZP, et al. Targeting microglial autophagic degradation of the NLRP3 inflammasome for identification of thonningianin A in Alzheimer\u2019s disease. Inflamm Regen. 2022;42(1):25.","journal-title":"Inflamm Regen"},{"issue":"11","key":"2698_CR28","doi-asserted-by":"publisher","first-page":"3833","DOI":"10.1080\/15548627.2021.1886720","volume":"17","author":"X Zheng","year":"2021","unstructured":"Zheng X, Lin W, Jiang Y, Lu K, Wei W, Huo Q, et al. Electroacupuncture ameliorates beta-amyloid pathology and cognitive impairment in Alzheimer disease via a novel mechanism involving activation of TFEB (transcription factor EB). Autophagy. 2021;17(11):3833\u201347.","journal-title":"Autophagy"},{"key":"2698_CR29","doi-asserted-by":"publisher","first-page":"8740284","DOI":"10.1155\/2018\/8740284","volume":"2018","author":"S Cui","year":"2018","unstructured":"Cui S, Xu M, Huang J, Wang QM, Lai X, Nie B, et al. Cerebral responses to acupuncture at GV24 and bilateral GB13 in rat models of Alzheimer\u2019s Disease. Behav Neurol. 2018;2018:8740284.","journal-title":"Behav Neurol"},{"key":"2698_CR30","volume-title":"The mouse brain in stereotaxic coordinates","author":"G Paxinos","year":"2001","unstructured":"Paxinos G, Franklin BJ. The mouse brain in stereotaxic coordinates. 2nd ed. Amsterdam: Elsevier; 2001.","edition":"2"},{"key":"2698_CR31","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3389\/fnbeh.2018.00273","volume":"12","author":"S Kang","year":"2018","unstructured":"Kang S, Ha S, Park H, Nam E, Suh WH, Suh YH, et al. Effects of a dehydroevodiamine-derivative on synaptic destabilization and memory impairment in the 5xFAD, Alzheimer\u2019s disease mouse model. Front Behav Neurosci. 2018;12:273.","journal-title":"Front Behav Neurosci"},{"key":"2698_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.749336","volume":"13","author":"HJ Lee","year":"2022","unstructured":"Lee HJ, Park JH, Hoe HS. Idebenone regulates abeta and LPS-induced neurogliosis and cognitive function through inhibition of NLRP3 inflammasome\/IL-1beta axis activation. Front Immunol. 2022;13: 749336.","journal-title":"Front Immunol"},{"issue":"1","key":"2698_CR33","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12974-020-01948-5","volume":"17","author":"DC Shippy","year":"2020","unstructured":"Shippy DC, Wilhelm C, Viharkumar PA, Raife TJ, Ulland TK. beta-Hydroxybutyrate inhibits inflammasome activation to attenuate Alzheimer\u2019s disease pathology. J Neuroinflammation. 2020;17(1):280.","journal-title":"J Neuroinflammation"},{"key":"2698_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/sigtrans.2017.23","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu T, Zhang L, Joo D, Sun SC. NF-kappaB signaling in inflammation. Signal Transduct Target Ther. 2017;2: e17023.","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"2698_CR35","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1083\/jcb.201503023","volume":"210","author":"T Kimura","year":"2015","unstructured":"Kimura T, Jain A, Choi SW, Mandell MA, Schroder K, Johansen T, et al. TRIM-mediated precision autophagy targets cytoplasmic regulators of innate immunity. J Cell Biol. 2015;210(6):973\u201389.","journal-title":"J Cell Biol"},{"issue":"3","key":"2698_CR36","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/ni.2215","volume":"13","author":"CS Shi","year":"2012","unstructured":"Shi CS, Shenderov K, Huang NN, Kabat J, Abu-Asab M, Fitzgerald KA, et al. Activation of autophagy by inflammatory signals limits IL-1beta production by targeting ubiquitinated inflammasomes for destruction. Nat Immunol. 2012;13(3):255\u201363.","journal-title":"Nat Immunol"},{"issue":"11","key":"2698_CR37","doi-asserted-by":"publisher","first-page":"9587","DOI":"10.1074\/jbc.M110.202911","volume":"286","author":"J Harris","year":"2011","unstructured":"Harris J, Hartman M, Roche C, Zeng SG, O\u2019Shea A, Sharp FA, et al. Autophagy controls IL-1beta secretion by targeting pro-IL-1beta for degradation. J Biol Chem. 2011;286(11):9587\u201397.","journal-title":"J Biol Chem"},{"issue":"2","key":"2698_CR38","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrm.2017.95","volume":"19","author":"S Herzig","year":"2018","unstructured":"Herzig S, Shaw RJ. AMPK: guardian of metabolism and mitochondrial homeostasis. Nat Rev Mol Cell Biol. 2018;19(2):121\u201335.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"12","key":"2698_CR39","doi-asserted-by":"publisher","first-page":"3957","DOI":"10.1080\/15548627.2021.1898748","volume":"17","author":"M Paquette","year":"2021","unstructured":"Paquette M, El-Houjeiri L, Zirden LC, Puustinen P, Blanchette P, Jeong H, et al. AMPK-dependent phosphorylation is required for transcriptional activation of TFEB and TFE3. Autophagy. 2021;17(12):3957\u201375.","journal-title":"Autophagy"},{"issue":"8","key":"2698_CR40","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/ni.2639","volume":"14","author":"FJ Sheedy","year":"2013","unstructured":"Sheedy FJ, Grebe A, Rayner KJ, Kalantari P, Ramkhelawon B, Carpenter SB, et al. CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation. Nat Immunol. 2013;14(8):812\u201320.","journal-title":"Nat Immunol"},{"key":"2698_CR41","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3389\/fcell.2020.00167","volume":"8","author":"A Chevriaux","year":"2020","unstructured":"Chevriaux A, Pilot T, Derangere V, Simonin H, Martine P, Chalmin F, et al. Cathepsin B is required for NLRP3 inflammasome activation in macrophages, through NLRP3 interaction. Front Cell Dev Biol. 2020;8:167.","journal-title":"Front Cell Dev Biol"},{"issue":"7","key":"2698_CR42","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/cdd.2011.32","volume":"18","author":"D Vara","year":"2011","unstructured":"Vara D, Salazar M, Olea-Herrero N, Guzman M, Velasco G, Diaz-Laviada I. Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy. Cell Death Differ. 2011;18(7):1099\u2013111.","journal-title":"Cell Death Differ"},{"issue":"5","key":"2698_CR43","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1172\/JCI37948","volume":"119","author":"M Salazar","year":"2009","unstructured":"Salazar M, Carracedo A, Salanueva IJ, Hernandez-Tiedra S, Lorente M, Egia A, et al. Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells. J Clin Invest. 2009;119(5):1359\u201372.","journal-title":"J Clin Invest"},{"key":"2698_CR44","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.bbi.2017.08.004","volume":"67","author":"F Gao","year":"2018","unstructured":"Gao F, Xiang HC, Li HP, Jia M, Pan XL, Pan HL, et al. Electroacupuncture inhibits NLRP3 inflammasome activation through CB2 receptors in inflammatory pain. Brain Behav Immun. 2018;67:91\u2013100.","journal-title":"Brain Behav Immun"},{"issue":"1","key":"2698_CR45","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41582-019-0284-z","volume":"16","author":"L Cristino","year":"2020","unstructured":"Cristino L, Bisogno T, Di Marzo V. Cannabinoids and the expanded endocannabinoid system in neurological disorders. Nat Rev Neurol. 2020;16(1):9\u201329.","journal-title":"Nat Rev Neurol"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-023-02698-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-023-02698-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-023-02698-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T19:04:10Z","timestamp":1675537450000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-023-02698-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,2]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2698"],"URL":"https:\/\/doi.org\/10.1186\/s12974-023-02698-w","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,2]]},"assertion":[{"value":"25 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal care and experimental procedures were approved by the Animals Care and Use Committee of Guangzhou University of Chinese Medicine, in accordance with the <i>ARRIVE guidelines<\/i> and the <i>Guide for the Care and Use of Laboratory Animals<\/i> recommended by National Institutes of Health. This article did not contain any studies with human participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21"}}